Global Kinase Inhibitors Market 2022-2028

May 2022 | 77 pages | ID: GE229082E975EN
Gen Consulting Company

Abstracts

A protein kinase inhibitor is a type of enzyme inhibitor that can block the action of protein kinases. Protein kinase inhibitors can be subdivided according to the amino acid on a protein that they add the phosphate to (e.g serine, threonine or tyrosine) in order to inhibit phosphorylation of that amino acid. The global kinase inhibitors market market is projected to rise by USD 23 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 6.1 percent during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global kinase inhibitors market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the kinase inhibitors industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for kinase inhibitors can be segmented by product: serine/threonine kinase inhibitor, tyrosine kinase inhibitor. Among these, the tyrosine kinase inhibitor segment was accounted for the highest revenue generator in 2021. Kinase inhibitors market is further segmented by application: antineoplastic drugs, immunosuppressants, treatment of age-related macular degeneration (AMD). Based on region, the kinase inhibitors market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest share of the global kinase inhibitors market in 2021 and is anticipated to hold its share during the forecast period.

By product:

• serine/threonine kinase inhibitor
• tyrosine kinase inhibitor

By application:

• antineoplastic drugs
• immunosuppressants
• treatment of age-related macular degeneration (AMD)

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The tyrosine kinase inhibitor market is further segmented into receptor tyrosine kinase inhibitor, non-receptor tyrosine kinase inhibitor. The receptor tyrosine kinase inhibitor segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period.

The report has also analysed the competitive landscape of the global kinase inhibitors market with some of the key players being AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb (BMS), Eisai Co., Ltd., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, Pfizer Inc., Roche Holding AG, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global kinase inhibitors market.
• To classify and forecast the global kinase inhibitors market based on product, application, region.
• To identify drivers and challenges for the global kinase inhibitors market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global kinase inhibitors market.
• To identify and analyze the profile of leading players operating in the global kinase inhibitors market.

Why Choose This Report

• Gain a reliable outlook of the global kinase inhibitors market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Serine/threonine kinase inhibitor
Tyrosine kinase inhibitor

PART 6. MARKET BREAKDOWN BY APPLICATION

Antineoplastic drugs
Immunosuppressants
Treatment of age-related macular degeneration (AMD)

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb (BMS)
Eisai Co., Ltd.
F. Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
Pfizer Inc.
Roche Holding AG
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER